Maximum Strength Robitussin Cough+Chest Congestion DM
November 23rd, 2021
Allegations: Deceptively marketing products as “Maximum Strength” when the dosage of the active ingredients is less than or the same as the regular strength products
Browsing the "medicine" Tag
Zicam Products
November 4th, 2021
Allegations: Falsely advertising that products are “clinically proven to shorten colds” when there is no scientific evidence to support such claims
DG Infants’ Acetaminophen
October 15th, 2021
Allegations: Misleadingly marketing infants' medicine as different than children's medicine when both contain the same amount of the same active ingredient
Little Remedies Infant Fever + Pain Reliever Medicine
September 20th, 2021
Allegations: Falsely marketing medicine as specially formulated for infants when it contains the same amount of the active ingredient as the children’s product
CVS Health Infants’ Pain & Fever Acetaminophen
April 1st, 2021
Allegations: Misleadingly marketing that the product is specifically formulated for infants and charging more for the infants’ product when it contains the same formulation of the same active ingredient in the children’s version
Zarbee’s Naturals Nighttime Cough Syrup + Mucus
February 22nd, 2021
Allegations: False natural and chemical-free claims
Walgreens Fast-Release Quick Gels
February 19th, 2021
Allegations: Falsely marketing products as "fast-release" when they do not work faster than other products marketed as "fast-release"
Little Remedies Infant Fever + Pain Reliever
January 8th, 2021
Allegations: Misleadingly marketing that the product is specially formulated for infants and charging more for the infants’ product than Little Remedies Children’s Fever + Pain Reliever when the medicines contain the same amount of the same active ingredient
Equate Infant’s Pain & Fever Acetaminophen
November 5th, 2020
In August 2020, a class-action lawsuit was filed against Perrigo Company and Walmart for allegedly misleadingly marketing that Equate Infant’s
Up & Up Infants’ Acetaminophen Fever Reducer/Pain Reliever
October 7th, 2020
In September 2020, a class-action lawsuit was filed against Target for allegedly misleadingly marketing Up & Up™ Infants’ Acetaminophen Fever
Kroger’s Infants’ and Children’s Acetaminophen Medications
August 24th, 2020
In July 2020, a class-action lawsuit was filed against The Kroger Co. for allegedly misleadingly marketing Kroger® Infants’ Pain &
Rite Aid’s Infants’ and Children’s Acetaminophen Products
August 24th, 2020
August 2020: This case was transferred from state court to federal court. (Case No. 20-cv-5476, N.D. Cal.) June 2020: A
Walgreens Acetaminophen Medications
August 21st, 2020
In August 2020, a class-action lawsuit was filed against Walgreens for allegedly misleadingly marketing Infants’ Dye-Free Pain & Fever Acetaminophen
TopCare Infants’ and Children’s Acetaminophen Medications
August 21st, 2020
In July 2020, a class-action lawsuit was filed against Topco Associates for allegedly misleadingly marketing TopCare® Infants’ Pain & Fever
Equate Infant’s and Children’s Pain & Fever Acetaminophen
August 21st, 2020
In June 2020, a class-action lawsuit was filed alleging that Walmart misleads consumers by marketing Equate™ Infant’s Pain & Fever
Rite Aid’s Infants’ and Children’s Acetaminophen Medications
August 21st, 2020
In July 2020, a class-action lawsuit was filed against Rite Aid for allegedly misleadingly advertising its Infants’ Fever Reducer &
Tylenol® Rapid Release Gelcaps
July 31st, 2020
May 2020: A federal judge dismissed certain claims but allowed the false advertising claims to move forward. July 2019: The
Rite Aid Acetaminophen Rapid Release Gelcaps
July 31st, 2020
September 2019: A federal judge dismissed certain claims but allowed the false advertising claims to move forward. November 2018: A
Equate™ Rapid Release Products
July 31st, 2020
April 2019: A federal judge dismissed certain claims but allowed the false advertising claims to move forward. November 2018: A
Global Institute of Stem Cell Therapy and Research
July 24th, 2020
In May 2020, a class-action lawsuit was filed against Global Institute of Stem Cell Therapy and Research for allegedly: Misleadingly